Glembatumumab vedotin shows a innovative strategy in cancer therapy. This targeted agent carefully recognizes an protein found on multiple tumor cells, releasing a potent anti-cancer compound. Early patient trials https://www.targetmol.com/compound/glembatumumab_vedotin